Private equity-backed contact lend maker Bausch and Lomb is reportedly about to be taken over for $9bn.
The company will be acquired by Valiant, said the Wall Street Journal, citing people familiar with the matter.
Owner Warburg Pincus could seal a deal to sell the business as soon as next week.
However, one of the sources said that nothing is set in stone and the deal could fall apart, in which case Warburg would go ahead with its plans to float Bausch.
Warbung bought Bausch for $4.5bn take-private including debt financing of $830m in 2007.
Back in March it was reported that the company was looking to raise $100m via an IPO and that Warburg was still considering a private sale of the company and had hired Goldman Sachs to find a suitor.
Warburg Pincus has invested over $8.1bn in more than 140 healthcare companies.
In addition to Bausch, some of its investees included American Medical Systems, Bausch + Lomb, Coventry Health Care, Eurand, Euromedic International, Harbin Pharmaceuticals, Lepu Medical Technology, RegionalCare Hospital Partners, Rural/Metro Corporation, Tornier and Zentiva.
Copyright © 2013 AltAssets